• Brand Name - Lamivir
  • Innovator Brand Name - Epivir
  • API - Lamivudine
  • Packaging - 60 Tablets
  • Strength - 150mg, 300mg
  • Manufacturer Name - Cipla Ltd


LAMIVUDINE is an antiretroviral medication indicated for the treatment of: 

HIV/AIDS: Lamivudine used for the prevention and treatment of HIV infection. Lamivudine is effective against both HIV-1 and HIV-2. 

Hepatitis B: It is also used to treat chronic hepatitis B when other options are not possible. 

Lamivudine commonly known as 3TC, and it is typically used in combination with other antiretrovirals such as zidovudine and abacavir.

Lamivudine Dosage

Lamivudine should be taken orally at about the same time each day, either with or without food. Lamivudine tablets should be swallowed whole with water. The tablets should not be opened, broken, or chewed.

Lamivudine tablets side effects
  • Most common side effects of Lamivudine include nausea, general discomfort, runny nose, diarrhea, unusual muscle pain, trouble breathing, stomach pain, dizziness, feeling cold, feeling very weak, loss of appetite, dark urine, clay-colored stools, yellowing of the skin or eyes, headaches, feeling tired, and cough.
  • It is safe for people over three months of age and can be used during pregnancy.
Warnings and Precautions
  • Long-term use of lamivudine 300 mg can trigger a resistant hepatitis B virus (YMDD) mutant.
  • Use with caution for patients with impaired renal function and do not prescribe this treatment to patients with impaired hepatic function.
  • Autoimmune disorders have been reported and symptoms can occur many months after initiation of antiretroviral therapy.
  • Patients who are infected with HIV and HCV and are on both interferon and lamivudine can experience liver damage.
  • HIV or HBV-infected women on lamivudine are warned to discontinue breastfeeding as this puts the baby at risk for HIV transmission and medication side effects.
  • Do not prescribe lamivudine/zidovudine, abacavir/lamivudine, or abacavir/lamivudine/zidovudine to patients taking emtricitabine.
  • Lamivir 150 mg  is contraindicated in patients with previous hypersensitivity reactions to lamivudine.
  • The drug can trigger an inflammatory response to opportunistic infections such as Pneumocystis jirovecii, (MAC) Mycobacterium avium complex, cytomegalovirus (CMV), and M. tuberculosis.
  • Are pregnant or having an intention to become pregnant. The consumption of Lamivudine while on pregnancy has not been associated with an increased risk of birth defects. Discuss with your doctor/healthcare provider if you want to become pregnant.
  • Womens with this medication may be more likely to get serious liver problems or lactic acidosis, very overweight (obese), or have been taking nucleoside analog medicines for a long time.
Supplied/Storage and handling

Care should be exercised in the handling of LAMIVIR. LAMIVIR tablets should not be opened or crushed. Store permitted between 15-30°C (59-86°F).

Drug Interactions of Lamivudine

Coadministration of lamivudine and sorbitol might decrease the concentrations of lamivudine. Co-administration should be avoided at every needful juncture.

Commonly asked questions:

Lamivudine also can be addressed as 3TC, which is an antiretroviral medication used to prevent and treat HIV/AIDS.

The active ingredient is Lamivudine, and the inactive ingredients are black iron oxide, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate, and titanium dioxide.

YES, this drug is typically used in combination with zidovudine and abacavir. Which are antiretroviral.


In fixed-dose combinations, Lamivudine is available with some other HIV drugs which are as follows:

  • Abacavir/lamivudine (with abacavir)
  • Abacavir/lamivudine/zidovudine (with zidovudine and abacavir)
  • Lamivudine/zidovudine (with zidovudine)

Lamivudine is a nucleoside reverse transcriptase inhibitor.

Lamivudine is an analogue of cytidine which is prescribed for the treatment of:

  • Both types (1 and 2) of HIV.
  • Hepatitis B virus.

Yes, on November 17, 1995 Lamivudine was approved by the FDA (Food and Drug Administration) for use with zidovudine (AZT) and again in 2002 as a once-a-day dosed medication.

Yes, Lamivudine is available in fixed-dose combinations with other HIV drugs such as:

  • Lamivudine/zidovudine (with zidovudine).
  • Abacavir/lamivudine (with abacavir).
  • Abacavir/lamivudine/zidovudine (with zidovudine and abacavir).

Patients who are allergic to the ingredients of the medicine.
Patients who are pregnant or planning to get pregnant.
Patients with Hepatitis B or C Co-infection.
Risk of Pancreatitis.
Patients with lactic acidosis.

  • You can buy Lamivudine 150 mg and Lamivudine 300 mg from any authorized whole seller after getting prescription from a qualified doctor. It is always better to check the credential of the whole seller/supplier/exporter before buying the product.
  • The buyer should check the existing law in their home country before importing the product.

Patients can simply fill the order form or can send mail at Patient can also send WhatsApp message to +91 8130290915. We will reply ASAP with the details of Pricing and procedure.
Note:- The order will be confirmed only after the receipt of Valid prescription of Clinician

Store the medicine Lamivudine between 15-30°C (59-86°F).


All Trademark and Brand that appear on the website belong to their respective owners and Ikris Pharma Network does not lay and claim on them we only provide Information. Lamivudine is a pharmaceutical drug that legally requires a medical prescription to be dispensed.

Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller and Pharmacies.